4.2 Article

Active Intrapartum SARS-CoV-2 Infection and Pregnancy Outcomes

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

COVID-19 vaccines in pregnancy

Marta C. Nunes et al.

Summary: COVID-19 caused by the SARS-CoV-2 coronavirus is associated with severe illness in pregnant women and can result in adverse fetal outcomes. Initially, pregnant women were excluded from clinical trials of the COVID-19 vaccines, but they have now been included in the vaccination programs. This review focuses on the safety, immunogenicity, and effectiveness of the mRNA COVID-19 vaccines in pregnant women.

TRENDS IN MOLECULAR MEDICINE (2022)

Article Immunology

Association of Group B Streptococcus (GBS) Serum Serotype-Specific Anticapsular Immunoglobulin G Concentration and Risk Reduction for Invasive GBS Disease in South African Infants: An Observational Birth-Cohort, Matched Case-Control Study

Shabir A. Madhi et al.

Summary: The study found an association between IgG concentrations of GBS serotypes Ia and III and a 90% reduction in risk of IGbsD in infants aged <= 90 days. This supports the case for licensure of a GBS polysaccharide-protein conjugate vaccine based on immunogenicity evaluation benchmarked against defined thresholds.

CLINICAL INFECTIOUS DISEASES (2021)

Article Obstetrics & Gynecology

Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study

Najeh Hcini et al.

Summary: Most pregnant women infected with SARS-CoV-2 during delivery were asymptomatic, with only a small percentage developing mild or severe symptoms. Infected mothers had higher risks of post-partum hemorrhage, transfusions, and ICU admissions compared to uninfected ones, as well as a higher risk of intra-uterine fetal demise. No differences were observed in other maternal, obstetrical, or neonatal outcomes between the two groups.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2021)

Article Pediatrics

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection The INTERCOVID Multinational Cohort Study

Jose Villar et al.

Summary: This study evaluated the risks associated with COVID-19 in pregnancy on maternal and neonatal outcomes compared with pregnant individuals without COVID-19, finding that pregnant individuals with COVID-19 were at higher risk for various complications such as preeclampsia, severe infections, and preterm birth. The findings emphasize the importance for pregnant individuals and clinicians to strictly implement recommended COVID-19 preventive measures.

JAMA PEDIATRICS (2021)

Article Medicine, General & Internal

Association of Maternal Perinatal SARS-CoV-2 Infection With Neonatal Outcomes During the COVID-19 Pandemic in Massachusetts

Asimenia Angelidou et al.

Summary: This multicenter cohort study in Massachusetts examined the percentage of neonates born to mothers with positive SARS-CoV-2 test results and factors associated with neonatal test result positivity. The study found that maternal social vulnerability was a significant risk factor for neonatal test result positivity, and adverse outcomes in newborns were linked to preterm delivery due to worsening maternal COVID-19 symptoms.

JAMA NETWORK OPEN (2021)

Article Multidisciplinary Sciences

COVID-19 and pregnancy: An umbrella review of clinical presentation, vertical transmission, and maternal and perinatal outcomes

Agustin Ciapponi et al.

Summary: This overview of systematic reviews summarized the evidence on the impact of COVID-19 on maternal and child health, indicating that pregnant women with COVID-19 may face increased risks of adverse pregnancy and birth outcomes. The most common clinical findings during pregnancy included fever, respiratory symptoms, raised C-reactive protein, lymphopenia, and pneumonia signs. Babies born to mothers with COVID-19 were most commonly asymptomatic, but may also experience fever, low birth weight, or preterm delivery. The odds of receiving invasive ventilation for COVID-19 pregnant women was 1.88 times higher than non-COVID-19 pregnant women, with a 3.13 times higher odds of their babies being admitted to the neonatal intensive care unit.

PLOS ONE (2021)

Review Public, Environmental & Occupational Health

A systematic review and meta-analysis of data on pregnant women with confirmed COVID-19: Clinical presentation, and pregnancy and perinatal outcomes based on COVID-19 severity

Zohra S. Lassi et al.

Summary: The study examined clinical presentation, risk factors, and outcomes of pregnant women with COVID-19, finding differences in severity based on age, comorbidities, and pregnancy outcomes. Pregnant women with severe COVID-19 were older and had higher risks of adverse outcomes such as preterm birth and neonatal complications. These findings could help guide guidelines and policies for managing pregnant women during the global COVID-19 pandemic.

JOURNAL OF GLOBAL HEALTH (2021)

Editorial Material Obstetrics & Gynecology

Classification system and case definition for SARS-CoV-2 infection in pregnant women, fetuses, and neonates

Prakesh S. Shah et al.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2020)

Letter Medicine, General & Internal

Seroprevalence and presentation of SARS-CoV-2 in pregnancy

Francesca Crovetto et al.

LANCET (2020)

Article Medicine, General & Internal

Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Emily H. Adhikari et al.

JAMA NETWORK OPEN (2020)

Article Public, Environmental & Occupational Health

Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020

Kate R. Woodworth et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Medical Laboratory Technology

Sampling and Definitions of Placental Lesions Amsterdam Placental Workshop Group Consensus Statement

T. Yee Khong et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)